1. Home
  2. LEGN vs FND Comparison

LEGN vs FND Comparison

Compare LEGN & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • FND
  • Stock Information
  • Founded
  • LEGN 2014
  • FND 2000
  • Country
  • LEGN United States
  • FND United States
  • Employees
  • LEGN N/A
  • FND N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • FND RETAIL: Building Materials
  • Sector
  • LEGN Health Care
  • FND Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • FND Nasdaq
  • Market Cap
  • LEGN 7.0B
  • FND 7.9B
  • IPO Year
  • LEGN 2020
  • FND 2017
  • Fundamental
  • Price
  • LEGN $27.78
  • FND $79.54
  • Analyst Decision
  • LEGN Strong Buy
  • FND Hold
  • Analyst Count
  • LEGN 13
  • FND 19
  • Target Price
  • LEGN $75.67
  • FND $94.68
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • FND 2.6M
  • Earning Date
  • LEGN 05-13-2025
  • FND 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • FND N/A
  • EPS Growth
  • LEGN N/A
  • FND N/A
  • EPS
  • LEGN N/A
  • FND 1.89
  • Revenue
  • LEGN $728,303,000.00
  • FND $4,519,221,000.00
  • Revenue This Year
  • LEGN $65.96
  • FND $7.59
  • Revenue Next Year
  • LEGN $52.55
  • FND $10.93
  • P/E Ratio
  • LEGN N/A
  • FND $42.02
  • Revenue Growth
  • LEGN 112.46
  • FND 2.96
  • 52 Week Low
  • LEGN $29.27
  • FND $66.01
  • 52 Week High
  • LEGN $60.87
  • FND $126.74
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • FND 56.15
  • Support Level
  • LEGN $30.25
  • FND $72.78
  • Resistance Level
  • LEGN $33.30
  • FND $86.23
  • Average True Range (ATR)
  • LEGN 1.78
  • FND 2.62
  • MACD
  • LEGN -0.57
  • FND 1.18
  • Stochastic Oscillator
  • LEGN 5.19
  • FND 57.69

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: